Roth Capital Resumes Panbella Therapeutics (PBLA) at Buy, PT $10
Tweet Send to a Friend
(Updated - January 31, 2023 10:07 AM EST)
Roth Capital analyst Jonathan Aschoff initiates coverage on Panbella Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Roth Capital analyst Jonathan Aschoff initiates coverage on Panbella Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
